New feature: Customize your PLUS research experience with
Skip to main content
- Answer Books
- Course Handbooks
Forms & Checklists
< Back To Results
1 in 1 results
Pfizer-Wyeth Merger Agreement, Provisions Related to Cash and Stock Considerations, Financing, and Termination and Reverse Fees
Mergers, Acquisitions and Tender Offers: Law and Strategies — Corporate, Securities, Taxation, Antitrust, Cross Border
Book Publication Date:
This document contains provisions of the merger agreement entered into on January 25, 2009 pursuant to which Pfizer was to acquire Wyeth, two publicly held firms.
The provisions relate principally to the stock and cash consideration to be paid by Pfizer, the financing conditions to the transaction and the Termination and Reverse Termination Fees.
Other Document Templates, Contract Clauses
PLI Item #:
Corporate & Securities
"Pfizer-Wyeth Merger Agreement, Provisions Related to Cash and Stock Considerations, Financing, and Termination and Reverse Fees"
"contract law drafting principles"
representations and warranties of company
"representations and warranties of parent and merger sub"
"covenants relating to conduct of business"
"effect on capital stock"
covenants relating to conduct of business
termination and amendment
Add To Bookshelf
Thank you for exploring PLI PLUS.
The content on this page is only available to subscribers.
To learn more about PLI PLUS subscriptions
please click on the link below or contact us at
Request More Info
Already a subscriber? Log in
All Contents Copyright © 1996-2020 Practising Law Institute.
About PLI PLUS
PLI Librarian Blog
PLI PLUS app
Continuing Legal Education since 1933.